STAAR Surgical CDO reports PSU vesting, tax withholding
STAAR Surgical Chief Development Officer Magda Michna reported compensation-related share activity tied to performance stock units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
STAAR Surgical Chief Development Officer Magda Michna reported compensation-related share activity tied to performance stock units. On May 15, 2026, multiple tranches of 2025 Performance Stock Units vested and were settled into a total of 19,795 shares of common stock. To cover tax obligations, 9,703 shares were withheld at a price of $32.07 per share. After these settlements and withholdings, Michna directly holds 38,093 shares of common stock and 10,997 remaining performance stock units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Performance Stock Units | 10,997 | $0.00 | $0.00 |
| Exercise | Performance Stock Units | 5,499 | $0.00 | $0.00 |
| Exercise | Performance Stock Units | 2,199 | $0.00 | $0.00 |
| Exercise | Performance Stock Units | 1,100 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 10,997 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 5,595 | $32.07 | $179K |
| Grant/Award | Common Stock | 5,499 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 2,431 | $32.07 | $78K |
| Grant/Award | Common Stock | 2,199 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 1,118 | $32.07 | $36K |
| Grant/Award | Common Stock | 1,100 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock | 559 | $32.07 | $18K |
Footnotes (8)
- F1. On May 15, 2026, the first tranche of 10,997 performance stock units ("PSUs") awarded to the Reporting Person under the Issuer's 2025 Performance Stock Unit Award Program ("2025 PSU Program") in connection with her annual equity grant vested, of which 5,595 shares were withheld to satisfy taxes .
- F2. On May 15, 2026, the second tranche of 5,499 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her annual equity grant vested, of which 2,431 shares were withheld to satisfy taxes.
- F3. On May 15, 2026, the first tranche of 2,199 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her promtion to Chief Development Officer vested, of which 1,118 shares were withheld to satisfy taxes.
- F4. On May 15, 2026, the second tranche of 1,100 PSUs awarded to the Reporting Person under the 2025 PSU Program in connection with her promtion to Chief Development Officer vested, of which 599 shares were withheld to satisfy taxes.
- F5. Represents the settlement of the first tranche of performance stock units awarded to the Reporting Person in connection with her annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
- F6. Represents the settlement of the second tranche of performance stock units awarded to the Reporting Person in connection with her annual equity grant under the 2025 PSU Program. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
- F7. Represents the settlement of the first tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with her promtion to Chief Development Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
- F8. Represents the settlement of the second tranche of performance stock units awarded under the 2025 PSU Program to the Reporting Person in connection with her promtion to Chief Development Officer. The number of shares earned was determined upon certification by the Compensation Committee based on achievement of applicable performance goals. The original grant was exempt pursuant to Rule 16b-3(d) and was not previously reported.
Key Figures
Key Terms
Performance Stock Units financial
2025 Performance Stock Unit Award Program financial
tax-withholding disposition financial
vesting financial
Rule 16b-3(d) regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did STAAR Surgical (STAA) executive Magda Michna report in this Form 4?
What are Magda Michna’s STAAR Surgical holdings after these transactions?
Were these STAAR Surgical transactions open-market buys or sells by Magda Michna?
What is the 2025 PSU Program mentioned in the STAAR Surgical Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.